Air Fluidized Therapy (AFT) in Patients With Suspected Deep Tissue Injury (sDTI)
NCT ID: NCT01292980
Last Updated: 2011-02-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
5 participants
OBSERVATIONAL
2010-08-31
2011-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Low-Intensity Blood Flow Restriction Therapy on the Management of Acute Ankle Sprains
NCT05596162
Pneumatic Compression vs Blood Flow Restriction for Muscle Recovery
NCT06815367
Blood Flow Restriction Therapy in Achilles Injury
NCT04104126
Sequential Compression Devices for Treatment of Restless Legs Syndrome
NCT00479531
Assessing Connected-Health, Pressure-Monitoring Technology for Improving Compression Therapy in Venous Leg Ulcer Treatment
NCT07152717
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Information including the pertinent history of current illness, co-morbid conditions, and demographic information will be shared with the sponsor in order to demonstrate each case.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AFT bed
All identified patients will receive a AFT bed for a maximum of 21 days or until discharge
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patient does not require a pulmonary specialty bed for care
3. Patient is expected to be in the hospital for at least 3 days
4. Patient weighs between 30 and 350 Lbs.
5. Patient's height is less than 75 inches tall
6. Patient, or patient's representative, is willing and able to sign written informed consent
7. Patient is expected to survive hospitalization.
Exclusion Criteria
2. Patient has already participated in this study
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hill-Rom
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hill-Rom
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Harris Methodist Hospital
Fort Worth, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CR-2009-08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.